Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1064737.RAq3E16_1IM6UiJaLGFSNWoHVkUezlifIuNR5w6spm2Sg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1064737.RAq3E16_1IM6UiJaLGFSNWoHVkUezlifIuNR5w6spm2Sg130_assertion type Assertion NP1064737.RAq3E16_1IM6UiJaLGFSNWoHVkUezlifIuNR5w6spm2Sg130_head.
- NP1064737.RAq3E16_1IM6UiJaLGFSNWoHVkUezlifIuNR5w6spm2Sg130_assertion description "[Autoantibodies to insulin (IAA), GAD (GADA), insulinoma-associated antigen-2 (IA-2A) and zinc transporter 8 (ZnT8A) were measured in follow-up sera, and genotyping for type 1 diabetes susceptibility genes (HLA-DR/HLA-DQ, INS variable number of tandem repeats [VNTR] and single nucleotide polymorphisms at PTPN22, PTPN2, ERBB3, IL2, SH2B3, CTLA4, IFIH1, KIAA0350 [also known as CLEC16A], CD25, IL18RAP, IL10, COBL) was performed on the DNA samples of children born to a parent with type 1 diabetes and prospectively followed from birth for up to 22�years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1064737.RAq3E16_1IM6UiJaLGFSNWoHVkUezlifIuNR5w6spm2Sg130_provenance.
- NP1064737.RAq3E16_1IM6UiJaLGFSNWoHVkUezlifIuNR5w6spm2Sg130_assertion evidence source_evidence_literature NP1064737.RAq3E16_1IM6UiJaLGFSNWoHVkUezlifIuNR5w6spm2Sg130_provenance.
- NP1064737.RAq3E16_1IM6UiJaLGFSNWoHVkUezlifIuNR5w6spm2Sg130_assertion SIO_000772 23539116 NP1064737.RAq3E16_1IM6UiJaLGFSNWoHVkUezlifIuNR5w6spm2Sg130_provenance.
- NP1064737.RAq3E16_1IM6UiJaLGFSNWoHVkUezlifIuNR5w6spm2Sg130_assertion wasDerivedFrom befree-2016 NP1064737.RAq3E16_1IM6UiJaLGFSNWoHVkUezlifIuNR5w6spm2Sg130_provenance.
- NP1064737.RAq3E16_1IM6UiJaLGFSNWoHVkUezlifIuNR5w6spm2Sg130_assertion wasGeneratedBy ECO_0000203 NP1064737.RAq3E16_1IM6UiJaLGFSNWoHVkUezlifIuNR5w6spm2Sg130_provenance.